Table 3 Treatment and vasopressor use characteristics
From: Timing of vasopressor initiation and mortality in septic shock: a cohort study
Treatment | Number | Percentage |
|---|---|---|
Steroids | 1,893 | 21.8 |
Activated protein C | 292 | 3.4 |
Source control required | 2,564 | 39.4 |
Pressor/inotrope agents used in first 24Â hours | ||
 Norepinephrine | 4,376 | 67.2 |
 Dopamine | 3,502 | 53.8 |
 Phenylephrine | 1,466 | 22.5 |
 Dobutamine | 793 | 12.2 |
 Vasopressin | 708 | 10.7 |
 Epinephrine | 313 | 4.8 |